DKSC (Dakshidin) Research & Development: $ Mil (TTM As of Sep. 2023)


What is Dakshidin Research & Development?

Dakshidin DKSC +33.33% Research & Development is $ Mil as of Sep. 2023.

Research & Development is the aggregate amount of research and development expenses during the year. Dakshidin's Research & Development for the three months ended in Sep. 2023 was $0.00 Mil. Dakshidin does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Sep. 2023.

Dakshidin  (OTCPK:DKSC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dakshidin Research & Development Related Terms

Dakshidin Research & Development Historical Data

* Premium members only.

The historical data trend for Dakshidin's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dakshidin Research & Development Chart

Dakshidin Annual Data
Trend
Research & Development

Dakshidin Quarterly Data
Mar19 Mar20 Sep22 Sep23
Research & Development 0.00 0.00 0.00 0.00

Dakshidin Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $ Mil mean?
Dakshidin (DKSC) has a Research & Development of $ Mil as of Sep. 2023. Research and development expense is the total cost for research and development activities. View historical data on Dakshidin and its competitors.
Is Dakshidin's Research & Development too high?
Dakshidin's current Research & Development is $ Mil.
How does Dakshidin's Research & Development compare to ECEZ and AFBG?
Dakshidin's Research & Development of $ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Dakshidin and its competitors. Dakshidin's current Research & Development is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dakshidin stock overvalued right now?
Dakshidin (DKSC) has a current Research & Development of $ Mil. The current Research & Development is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Dakshidin (DKSC), the current Research & Development is $ Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dakshidin Business Description

Address 508 Locust Street, Lockport, NY, USA, 14094
Dakshidin Corp is a Cannabis-based medical product company. The company operates through its online e-commerce store laughingfrogs.com. The company is composed of four synergistic entities: Laughing Frogs, an online sales portal for the company's CBD products; Laughing Frogs Nutraceutical the online sales portal for all non-CBD hemp oil products and its proprietary nutraceutical products, company's new PPE division and Runnymede Farms, a company that is focused on the cultivation of specifically grown Hemp plants. through its growing operations and Joint Ventures with established growers.